Mario Petrini

CD8 expression in B-cell non-Hodgkin's lymphomas.

Bone and bone-marrow interactions: haematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. Mobilizing properties on white blood cells and peripheral blood stem cells in mice.

Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide. II. Action on human hematopoietic stem cells.

Peripheral blood stem cell contamination evaluated by a highly sensitive molecular method fails to predict outcome of autotransplanted multiple myeloma patients.

Carboxy-terminal fragment of osteogenic growth peptide in vitro increases bone marrow cell density in idiopathic myelofibrosis.

Efficacy and toxicity of liposomal daunorubicin included in PVABEC regimen for aggressive NHL of the elderly.

FLT3 mutations do not influence MDR-1 gene expression in acute myeloid leukemia.

Lithium effects on neutrophil motility in Shwachman-Diamond syndrome: evaluation by computer-assisted image analysis.

Expansion of TcRalphabeta+CD3+CD4-CD8- (CD4/CD8 double-negative) T lymphocytes in a case of staphylococcal toxic shock syndrome.

Evaluation of BCRP and MDR-1 co-expression by quantitative molecular assessment in AML patients.

Bilateral primary renal lymphoma treated by surgery and chemotherapy.

Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide III. Action on human megakaryocytopoiesis: focus on essential thrombocythemia.

Quantitative molecular evaluation of minimal residual disease in patients with chronic lymphocytic leukemia: efficacy of in vivo purging by alemtuzumab (Campath-1H).

Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA.

Rituximab as treatment for minimal residual disease in hairy cell leukaemia.

Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA.

Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation.

Imatinib therapy in Hypereosinophilic Syndrome: a case of molecular remission.

[Bone marrow infiltration in B-cell non-Hodgkin's lymphomas: comparison between flow cytometry and bone marrow biopsy].

Quantitative molecular monitoring of BCR-ABL and MDR1 transcripts in patients with chronic myeloid leukemia during Imatinib treatment.

Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.

Different gamma/delta T clones sustain GVM and GVH effects in multiple myeloma patients after non-myeloablative transplantation.

Effect of epirubicin-based chemotherapy and dexrazoxane supplementation on QT dispersion in non-Hodgkin lymphoma patients.

Primary lymphoma of the bladder: case report.

Chimerism does not influence graft-versus-myeloma and graft-versus-host disease in reduced intensity setting.

Cytoplasmic nucleophosmin in myeloid sarcoma occurring 20 years after diagnosis of acute myeloid leukaemia.

Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.

More on donor-derived T-cell leukemia after bone marrow transplantation.

Simultaneous appearance of acute myeloid leukemia in a patient with bilateral primary uveal melanoma.

Bortezomib inhibits T-cell function versus infective antigenic stimuli in a dose-dependent manner in vitro.

Match unrelated bone marrow transplantation in a case of high risk myelodysplastic syndrome treated with azacitidine and concomitant 1alpha-25-dihydroxyvitamin D3, as differentiating agent.

Folate levels and methylation of CDKI proteins.

Progressive multifocal leukoencephalopathy in a haploidentical stem cell transplant recipient: a clinical, neuroradiological and virological response after treatment with risperidone.

CD19/CD8 coexpression in B-chronic lymphocytic leukemia.

PEG-Filgrastim activity on granulocyte functions.

A therapy resistant myelodysplastic syndrome characterized by the presence of the rare reciprocal translocation t(3;12)(q26.2;p13).

Folate levels in cancer: a vitamin for a new challenge.

Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.

Gliptins.

Poor prognosis chronic myeloid leukemia with a complex variant Philadelphia translocation, t(9;10;22)(q34;q24;q11).

NQO1*2 polymorphism and response to treatment in patients with multiple myeloma.

Concomitant translocation t(14;22)(q32;q11) in a case of chronic myeloid leukemia.

Complex translocation t(3;9;22)(q21;q34;q11) at diagnosis is a negative prognostic index in chronic myeloid leukemia.

Reduction of immunoglobulin levels during imatinib therapy of chronic myeloid leukemia.

CD57 expression on lymphoma microenvironment as a new prognostic marker related to immune dysfunction.

Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis.

Complex translocation t(6;9;22)(p21.1;q34;q11) at diagnosis is a therapy resistance index in chronic myeloid leukaemia.

Two cases of plasma cell leukemia with atypical immunophenotype.

Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia.

MDR1 polymorphism influences the outcome of multiple myeloma patients.

Hypothesis: central nervous system delivery of cyclosporine A for therapy of progressive multifocal leukoencephalopathy.

Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms.

Stable low IgG levels in relapsed non-Hodgkin's lymphomas.

Association of PIM gene translocation and TEL/AML1 rearrangement.

Unexpected cardiotoxicity in haematological bortezomib treated patients.

RAF-1 over-expression does condition survival of patients affected by aggressive mantle cell lymphoma.

Comment on "Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells".

Effects of Aspergillus fumigatus gliotoxin and methylprednisolone on human neutrophils: implications for the pathogenesis of invasive aspergillosis.

CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.

Evaluation of the MDR1, ABCG2, Topoisomerases IIalpha and GSTpi gene expression in patients affected by aggressive mantle cell lymphoma treated by the R-Hyper-CVAD regimen.

MDR1 pump: more than a drug transporter comment on "Regulatory polymorphisms of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukaemia" by Hattori et al. [Leuk. Res. (in press)].

Acute myeloid leukemia and follicular lymphoma after very low dose radioiodine therapy for thyroid diseases.

Long-term propylthiouracil use and acute myeloid leukemia: a case report and review of the literature.

Concomitant appearance of trisomy 8 and isochromosome 17q in a Philadelphia-positive clone in a patient with chronic myeloid leukemia in chronic phase: an alarm for changing therapeutic strategy.

Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing.

Suspension of bone marrow-derived undifferentiated mesenchymal stromal cells for repair of superficial digital flexor tendon in race horses.

Hairy Cell Leukemia.

Unusual association of endometrial cancer and multiple myeloma.

Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk.

Progressive multifocal leukoencephalopathy: report of three cases in HIV-negative hematological patients and review of literature.

False positive PET scanning caused by inactivated influenza virus vaccination during complete remission from anaplastic T-cell lymphoma.

Bortezomib is able to reduce angiogenesis in half of patients affected by idiopathic myelofibrosis: an ex vivo study.

5-HT2a inhibitors for progressive multifocal leukoencephalopathy: old drugs for an old disease.

Other mechanisms to explain the role of reduced folate carrier in cancer.

Phenobarbital-associated bone marrow aplasia: a case report and review of the literature.

JC viremia and multiple sclerosis.

Acute myeloid leukaemia after treatment with (90)Y-ibritumomab tiuxetan for follicular lymphoma.

MDR1 diplotypes as prognostic markers in multiple myeloma.

Folic acid fortification and cancer risk.

JAK-2V617F mutation in RARS-t: a target for Imatinib therapy?

Morpho-functional characterization of human mesenchymal stem cells from umbilical cord blood for potential uses in regenerative medicine.

Gelatin/PLLA sponge-like scaffolds allow proliferation and osteogenic differentiation of human mesenchymal stromal cells.

The small peptide OGP(10-14) acts through Src kinases and RhoA pathways in Mo-7e cells: morphologic and immunologic evaluation.

Conditioning response to granulocyte colony-stimulating factor via the dipeptidyl peptidase IV-adenosine deaminase complex.

Enhancement of hematopoietic stem cell engraftment by inhibition of CXCL12 proteolysis with sitagliptin, an oral dipeptidyl-peptidase IV inhibitor: a report in a case of delayed graft failure.

Sialic acid moieties and 5-HT2a: two faces of the same receptor for JC virus?

Changes In CD8+57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia.

MDR1 modulates apoptosis in CD34+ leukemic cells.

Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature.

Good manufacturing practice-grade fibrin gel is useful as a scaffold for human mesenchymal stromal cells and supports in vitro osteogenic differentiation.

Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.

Lithium and hematology: established and proposed uses.

Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma.

Identification and purification of mesodermal progenitor cells from human adult bone marrow.

Considerations in the treatment of multiple myeloma: a consensus statement from Italian experts.

Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy.

Expression of the oncofetal ED-B-containing fibronectin isoform in hematologic tumors enables ED-B-targeted 131I-L19SIP radioimmunotherapy in Hodgkin lymphoma patients.

Meningeal relapse in a case of B acute lymphoblastic leukemia: the role of CD56 expression.

JC virus DNA in healthy brain tissue: a challenge for progressive multifocal leukoencephalopathy diagnosis.

Novel biological/biohybrid prostheses for the ossicular chain: fabrication feasibility and preliminary functional characterization.

Fatal ongoing human cytomegalovirus reactivation during high-dose melphalan and autologous stem cell transplantation.

Selective culture of mesodermal progenitor cells.

Development of tissue-engineered substitutes of the ear ossicles: PORP-shaped poly(propylene fumarate)-based scaffolds cultured with human mesenchymal stromal cells.

Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage Hodgkin lymphoma in the pre-positron emission tomography era: a Gruppo Italiano Studio Linfomi (GISL) prospective trial.

2CdA chemotherapy and rituximab in the treatment of marginal zone lymphoma.

Polyomaviruses other than JCV are not detected in progressive multifocal leukoencephalopathy.

The role of bone marrow cells for JCV pathogenicity.

Hypercytokinemia-induced metabolic encephalopathy in a multiple myeloma patient on hemodialysis undergoing autologous stem cell transplantation: clinical response after plasma exchange.

Aberrant expression of CD8 in B-cell non-Hodgkin lymphoma: a multicenter study of 951 bone marrow samples with lymphomatous infiltration.

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project.

Re: Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin's lymphomas treated with rituximab.

Bortezomib and liposomal doxorubicin are highly effective in obtaining the best possible response before autologous transplant for multiple myeloma.

MDR1 C3435T polymorphism indicates a different outcome in advanced multiple myeloma.

Platelet-derived growth factor beta receptor (PDGFRB) gene is rearranged in a significant percentage of myelodysplastic syndromes with normal karyotype.

Consistent bone marrow-derived cell mobilization following repeated short courses of granulocyte-colony-stimulating factor in patients with amyotrophic lateral sclerosis: results from a multicenter prospective trial.

CD57+ T lymphocytes and functional immune deficiency.

Fludarabine, Bortezomib, Myocet and rituximab chemotherapy in relapsed and refractory mantle cell lymphoma.

In vitro and in vivo study on the antioxidant activity of dexrazoxane.

Torquetenovirus viremia kinetics after autologous stem cell transplantation are predictable and may serve as a surrogate marker of functional immune reconstitution.

WT1 expression levels at diagnosis could predict long-term time-to-progression in adult patients affected by acute myeloid leukaemia and myelodysplastic syndromes.

Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematology.

Areas with high soil percolation by herbicides have higher incidence of low-grade non-Hodgkin lymphomas.

Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib.

WU and KI polyomaviruses remain orphans in adults.

Constitutive expression of pluripotency-associated genes in mesodermal progenitor cells (MPCs).

Role of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia.

Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders.

Progressive multifocal leukoencephalopathy: what's new?

Glycosylation interference on RhoA activation: focus on G-CSF.

Barium Titanate Nanoparticles: Highly Cytocompatible Dispersions in Glycol-chitosan and Doxorubicin Complexes for Cancer Therapy.

CD23 expression in plasma cell leukaemia.

Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.

Enhancement of neurite outgrowth in neuronal-like cells following boron nitride nanotube-mediated stimulation.

Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathy.

Outcome of patients with mantle cell lymphoma is not influenced by vascular endothelial growth factor polymorphisms.

ITF2357 interferes with apoptosis and inflammatory pathways in the HL-60 model: a gene expression study.

Lenograstim reduces the incidence of febrile episodes, when compared with filgrastim, in multiple myeloma patients undergoing stem cell mobilization.

The small peptide OGP(10-14) reduces proliferation and induces differentiation of TPO-primed M07-e cells through RhoA/TGFbeta1/SFK pathway.

Pegylated liposomal doxorubicin in combination with dexamethasone and bortezomib (VMD) or lenalidomide (RMD) in multiple myeloma pretreated patients.

Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multicenter study.

A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patients.

High-dose (40,000 IU twice/week) alpha recombinant human erythropoietin as single agent in low/intermediate risk myelodysplastic syndromes: a retrospective investigation on 133 patients treated in a single institution.

Discordant lymphoma consisting of splenic mantle cell lymphoma and marginal zone lymphoma involving the bone marrow and peripheral blood: a case report.

Mesodermal progenitor cells (MPCs) differentiate into mesenchymal stromal cells (MSCs) by activation of Wnt5/calmodulin signalling pathway.

CD57 and γδ T-cell receptor expression in nodal metastatic spread of melanoma.

Lithium in the treatment of neutropenia.

Rituximab plus HyperCVAD alternating with high dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma, a multicentre trial from Gruppo Italiano Studio Linfomi.

Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review).

The role of CD19 and CD27 in the diagnosis of multiple myeloma by flow cytometry: a new statistical model.

Could age modify the effect of genetic variants in IL6 and TNF-α genes in multiple myeloma?

Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes.

Radioimmunotherapy with radretumab in patients with relapsed hematologic malignancies.

Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium.

Impaired function of gamma-delta lymphocytes in melanoma patients.

Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma.

Prethymic cytoplasmic CD3 negative acute lymphoblastic leukemia or acute undifferentiated leukemia: a case report.

Arsenic trioxide and ascorbic acid interfere with the BCL2 family genes in patients with myelodysplastic syndromes: an ex-vivo study.

HOX and TALE signatures specify human stromal stem cell populations from different sources.

B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy.

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus doxorubicin and dexamethasone as induction therapy in previously untreated multiple myeloma patients.

Polymorphisms in regulators of xenobiotic transport and metabolism genes PXR and CAR do not affect multiple myeloma risk: a case-control study in the context of the IMMEnSE consortium.

Specific integrin expression is associated with podosome-like structures on mesodermal progenitor cells.

Growing bone tissue-engineered niches with graded osteogenicity: an in vitro method for biomimetic construct assembly.

Simultaneous presentation of Waldenström macroglobulinemia and multiple myeloma: multidisciplinary diagnosis, treatment and 30-month follow-up.

Treatment of oral mucositis in hematologic patients undergoing autologous or allogeneic transplantation of peripheral blood stem cells: a prospective, randomized study with a mouthwash containing camelia sinensis leaf extract.

A Case of Primary Non-Hodgkin's Lymphoma of the External Auditory Canal.

Use of autologous human mesenchymal stromal cell/fibrin clot constructs in upper limb non-unions: long-term assessment.

Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia.

Boron nitride nanotubes and primary human osteoblasts: in vitro compatibility and biological interactions under low frequency ultrasound stimulation.

Safety and efficacy of (90) yttrium-ibritumomab-tiuxetan for untreated follicular lymphoma patients. An Italian cooperative study.

Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era.

Processing large-diameter poly(L-lactic acid) microfiber mesh/mesenchymal stromal cell constructs via resin embedding: an efficient histologic method.

Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length.

Plasticity of human dental pulp stromal cells with bioengineering platforms: a versatile tool for regenerative medicine.

Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.

Minimal residual disease after conventional treatment significantly impacts on progression-free survival of patients with follicular lymphoma: the FIL FOLL05 trial.

Myelomatous meningitis evaluated by multiparameter flow cytometry : report of a case and review of the literature.

Bortezomib and Arsenic Trioxide Activity on a Myelodysplastic Cell Line (P39): A Gene Expression Study.

Kinetics of hematogones in bone marrow samples from patients with non-Hodgkin lymphomas treated with rituximab-containing regimens: a flow cytometric study.

Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium.

CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.

Polycomb genes are associated with response to imatinib in chronic myeloid leukemia.

Ofatumumab maintenance versus observation in relapsed chronic lymphocytic leukaemia (PROLONG): an open-label, multicentre, randomised phase 3 study.

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia.

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.

Combination of CD157 and FLAER to Detect Peripheral Blood Eosinophils by Multiparameter Flow Cytometry.

Modifications in B-Lymphocyte Number and Phenotype in the Course of Pregnancy in a Woman with Persistent Polyclonal B-Cell Lymphocytosis: A Flow Cytometric Study.

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.

Mesangiogenic Progenitor Cells Derived from One Novel CD64(bright)CD31(bright)CD14(neg) Population in Human Adult Bone Marrow.

First report of Wautersiella falsenii genomovar 2 isolated from the respiratory tract of an immunosuppressed man.

Discrepancy between FLC assays: only a problem of quantification?

Grafting of Expanded Mesenchymal Stem Cells without Associated Procedure in a Healed Case of Ulna Pseudarthrosis: A Case Report.

A systematic literature review and network meta-analysis of treatments for patients with untreated multiple myeloma not eligible for stem cell transplantation.

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUSTM (MM-010): a phase 3b study in refractory multiple myeloma.

A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: Results from the IMMEnSE consortium and meta-analysis.

How to treat splenic marginal zone lymphoma (SMZL) in patients unfit for surgery or more aggressive therapies: experience in 30 cases.

ATP-binding cassette transmembrane transporters and their epigenetic control in cancer: an overview.

LH and FSH promote migration and invasion properties of a breast cancer cell line through regulatory actions on the actin cytoskeleton.

Genetic predisposition and induced pro-inflammatory/pro-oxidative status may play a role in increased atherothrombotic events in nilotinib treated chronic myeloid leukemia patients.

Identification of miRSNPs associated with the risk of multiple myeloma.